Ureter Cancer

• CLINICAL_TRIALS research · 2026-03-05
  Clinical Trial Update: Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery [EARLY_Phase 1]

  This early-phase trial update describes the combination of durvalumab and tremelimumab in cisplatin-ineligible muscle-invasive urothelial ca…

• CLINICAL_TRIALS trial_result · 2023-08-08
  Clinical Trial Update: Gemcitabine for the Prevention of Intravesical Recurrence of Urothelial Cancer in Patients With Upper Urinary Tract Urothelial Cancer Undergoing Radical Nephroureterectomy, GEMINI Study [Phase 2]

  Phase 2 trial evaluating gemcitabine to prevent intravesical recurrence of urothelial cancer in patients with upper tract urothelial cancer …

• CLINICAL_TRIALS trial_result · 2021-11-23
  Clinical Trial Update: Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases [Phase 2]

  Phase 2 trial comparing denosumab with standard treatment in urothelial cancer patients with bone metastases has completed.

• CLINICAL_TRIALS trial_result · 2020-09-10
  Clinical Trial Update: Erlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial Cancer [Phase 2]

  Phase 2 clinical trial evaluating erlotinib hydrochloride in patients with muscle-invasive or recurrent urothelial cancer has completed, wit…

• CLINICAL_TRIALS trial_result · 2019-12-16
  Clinical Trial Update: Gemcitabine Hydrochloride and Eribulin Mesylate in Treating Patients With Bladder Cancer That is Advanced or Cannot Be Removed by Surgery [Phase 2]

  Phase 2 clinical trial evaluating gemcitabine hydrochloride and eribulin mesylate in advanced or unresectable bladder, ureter, and urethral …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2019-05-16
  Clinical Trial Update: Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer [Phase 2]

  Phase 2 trial evaluating carboplatin and gemcitabine with or without vandetanib as first-line therapy for locally advanced or metastatic uri…

• CLINICAL_TRIALS trial_result · 2017-09-28
  Clinical Trial Update: Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial Carcinoma [Phase 3]

  A Phase 3 trial comparing four vs six cycles of cisplatin-based chemotherapy in metastatic urothelial carcinoma is ongoing/unknown status.

• CLINICAL_TRIALS withdrawal · 2014-01-29
  Clinical Trial Update: Gemcitabine Hydrochloride and Cisplatin or High-Dose Methotrexate, Vinblastine, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Urothelial Cancer [Phase 2]

  This Phase 2 clinical trial evaluating gemcitabine plus cisplatin or a high-dose methotrexate/vinblastine/doxorubicin/cisplatin regimen for …

• CLINICAL_TRIALS trial_result · 2011-12-07
  Clinical Trial Update: Study of Genexol-PM in Patients With Advanced Urothelial Cancer Previously Treated With Gemcitabine and Platinum [Phase 2]

  This is a completed Phase 2 clinical trial evaluating Genexol-PM in patients with advanced urothelial cancer (bladder or ureter cancer) prev…